Live Breaking News & Updates on Peter Choo

Stay updated with breaking news from Peter choo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

29.01.2024 - The Company now has exclusive rights to a Malaysia, US and China patentSINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) - CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on . Seite 1 ....

Peter Choo , Cytomed Therapeutics Limited , Cytomed Or Company , Property Corporation Of Malaysia , Exchange Commission , Med Therapeutics Limited , Intellectual Property Corporation , Deltat Cells , Tumoricidal Activity , License Agreement , Cytomed Therapeutics Chart , Ytomed Therapeutics Kurs , Ytomed Therapeutics Aktie ,

Foundation brings orthopaedic care to over 50 elderly Kelabit, Penan patients

Foundation brings orthopaedic care to over 50 elderly Kelabit, Penan patients
theborneopost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theborneopost.com Daily Mail and Mail on Sunday newspapers.

Datin Pearl Masna , Penghulu Caleena Sakai , Peter Choo , Australian High Commission , Yayasan Kesenian Orang Asli , Kesenian Orang Asli , Caleena Sakai , Miri Hospital , Australian High ,

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update


Conference call webcast is scheduled for November 22 at 9 a.m. ET. SINGAPORE, Nov. 17, 2023 /PRNewswire/ CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced its first half of 2023 financial results. ....

National University Hospital , Singapore General , Peter Choo , Cytomed Or Company , Health Sciences Authority , Cytomed Therapeutics Limited , Agency For Science , Good Manufacturing Practice , Six Months Ended June , Public Offering , Cash Equivalents ,